| 0.702 | 0.009 | 0.702 | Angiogenesis inhibitor | | |
| 0.645 | 0.004 | 0.645 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | | |
| 0.596 | 0.003 | 0.596 | MAP kinase kinase 2 inhibitor | | |
| 0.423 | 0.012 | 0.423 | Vascular endothelial growth factor antagonist | | |
| 0.411 | 0.012 | 0.411 | Vascular endothelial growth factor 2 antagonist | | |
| 0.375 | 0.005 | 0.375 | TIE antagonist | | |
| 0.366 | 0.005 | 0.366 | TIE-2 antagonist | | |
| 0.363 | 0.013 | 0.363 | Vascular endothelial growth factor 3 antagonist | | |
| 0.361 | 0.022 | 0.361 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | | |
| 0.332 | 0.004 | 0.332 | MAP kinase kinase kinase inhibitor | | |
| 0.319 | 0.031 | 0.319 | Ca2+/calmodulin-dependent kinase II beta inhibitor | | |
| 0.315 | 0.029 | 0.315 | ErbB-1 antagonist | | |
| 0.291 | 0.009 | 0.291 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | | |
| 0.282 | 0.005 | 0.282 | Raf kinase C inhibitor | | |
| 0.3 | 0.027 | 0.3 | Growth factor antagonist | | |
| 0.28 | 0.008 | 0.28 | Raf kinase inhibitor | | |
| 0.293 | 0.031 | 0.293 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | | |
| 0.278 | 0.024 | 0.278 | I kappa B kinase epsilon inhibitor | | |
| 0.372 | 0.123 | 0.372 | MAP kinase 1 inhibitor | | |
| 0.247 | 0.004 | 0.247 | Fibroblast growth factor 3 antagonist | | |
| 0.281 | 0.044 | 0.281 | Clk dual-specificity kinase inhibitor | | |
| 0.258 | 0.027 | 0.258 | Protein kinase (CK1) gamma 1 inhibitor | | |
| 0.254 | 0.028 | 0.254 | MAP kinase kinase 3 inhibitor | | |
| 0.256 | 0.03 | 0.256 | RET inhibitor | | |
| 0.265 | 0.041 | 0.265 | CDC-like kinase 4 inhibitor | | |
| 0.262 | 0.043 | 0.262 | TRKC antagonist | | |
| 0.236 | 0.019 | 0.236 | Vascular endothelial growth factor 1 antagonist | | |
| 0.262 | 0.052 | 0.262 | MAP-kinase-activated kinase 5 inhibitor | | |
| 0.231 | 0.02 | 0.231 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | | |
| 0.23 | 0.02 | 0.23 | Abl kinase inhibitor | | |
| 0.214 | 0.009 | 0.214 | Raf kinase B inhibitor | | |
| 0.234 | 0.029 | 0.234 | Lck kinase inhibitor | | |
| 0.245 | 0.046 | 0.245 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | | |
| 0.233 | 0.041 | 0.233 | Src kinase inhibitor | | |
| 0.202 | 0.016 | 0.202 | Fibroblast growth factor 1 antagonist | | |
| 0.207 | 0.021 | 0.207 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | | |
| 0.221 | 0.038 | 0.221 | Protein kinase (CK1) gamma inhibitor | | |
| 0.211 | 0.028 | 0.211 | TRKA antagonist | | |
| 0.22 | 0.039 | 0.22 | Protein-tyrosine kinase Lyn inhibitor | | |
| 0.213 | 0.034 | 0.213 | Tyrosine-protein kinase receptor FLT3 inhibitor | | |
| 0.199 | 0.024 | 0.199 | MAP kinase 3 inhibitor | | |
| 0.234 | 0.062 | 0.234 | Ca2+/calmodulin-dependent protein kinase inhibitor | | |
| 0.188 | 0.019 | 0.188 | Platelet activating factor alpha antagonist | | |
| 0.222 | 0.056 | 0.222 | CDC-like kinase 2 inhibitor | | |
| 0.205 | 0.039 | 0.205 | Tyrosine-protein kinase receptor antagonist | | |
| 0.181 | 0.019 | 0.181 | Insulin receptor antagonist | | |
| 0.174 | 0.013 | 0.174 | Platelet growth factor antagonist | | |
| 0.196 | 0.038 | 0.196 | Cyclin-dependent kinase 8 inhibitor | | |
| 0.22 | 0.065 | 0.22 | Death-associated protein kinase 3 inhibitor | | |
| 0.168 | 0.017 | 0.168 | p38 MAP kinase inhibitor | | |
| 0.198 | 0.048 | 0.198 | Protein kinase C nu inhibitor | | |
| 0.22 | 0.075 | 0.22 | EphB2 antagonist | | |
| 0.208 | 0.063 | 0.208 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | | |
| 0.195 | 0.05 | 0.195 | Protein kinase (CK1) gamma 3 inhibitor | | |
| 0.181 | 0.036 | 0.181 | MAP kinase kinase inhibitor | | |
| 0.182 | 0.037 | 0.182 | Protein kinase (CK1) gamma 2 inhibitor | | |
| 0.186 | 0.043 | 0.186 | Ribosomal protein S6 kinase inhibitor | | |
| 0.204 | 0.061 | 0.204 | LIM domain kinase 1 inhibitor | | |
| 0.192 | 0.05 | 0.192 | Polo-like kinase-3 inhibitor | | |
| 0.208 | 0.066 | 0.208 | Tyrosine kinase inhibitor | | |
| 0.23 | 0.095 | 0.23 | Ca2+/calmodulin-dependent kinase IV inhibitor | | |
| 0.151 | 0.019 | 0.151 | MAP kinase 14 inhibitor | | |
| 0.2 | 0.069 | 0.2 | Focal adhesion kinase 2 inhibitor | | |
| 0.196 | 0.066 | 0.196 | Growth factor agonist | | |
| 0.166 | 0.037 | 0.166 | Platelet activating factor antagonist | | |
| 0.149 | 0.023 | 0.149 | Insulin growth factor antagonist | | |
| 0.159 | 0.035 | 0.159 | Platelet activating factor beta antagonist | | |
| 0.163 | 0.039 | 0.163 | TRKB antagonist | | |
| 0.151 | 0.029 | 0.151 | EphA2 antagonist | | |
| 0.279 | 0.157 | 0.279 | MAP kinase kinase 6 inhibitor | | |
| 0.162 | 0.041 | 0.162 | Epidermal growth factor receptor kinase inhibitor | | |
| 0.212 | 0.092 | 0.212 | Dyrk kinase inhibitor | | |
| 0.171 | 0.055 | 0.171 | Ca2+/calmodulin-dependent kinase II delta inhibitor | | |
| 0.136 | 0.024 | 0.136 | Insulin like growth factor 1 antagonist | | |
| 0.129 | 0.019 | 0.129 | Rho-associated kinase I inhibitor | | |
| 0.144 | 0.04 | 0.144 | Polo-like kinase-4 inhibitor | | |
| 0.198 | 0.094 | 0.198 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | | |
| 0.126 | 0.024 | 0.126 | Bcr-Abl kinase inhibitor | | |
| 0.228 | 0.127 | 0.228 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | | |
| 0.142 | 0.046 | 0.142 | Protein kinase (CK2) alpha inhibitor | | |
| 0.157 | 0.062 | 0.157 | Glycogen synthase kinase-3 alpha inhibitor | | |
| 0.142 | 0.048 | 0.142 | MAP kinase 12 inhibitor | | |
| 0.153 | 0.059 | 0.153 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | | |
| 0.183 | 0.09 | 0.183 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | | |
| 0.135 | 0.042 | 0.135 | Ephrin antagonist | | |
| 0.154 | 0.063 | 0.154 | Activin receptor-like kinase 2 inhibitor | | |
| 0.122 | 0.032 | 0.122 | Epidermal growth factor antagonist | | |
| 0.169 | 0.088 | 0.169 | MAP kinase kinase 5 inhibitor | | |
| 0.14 | 0.061 | 0.14 | c-Src kinase inhibitor | | |
| 0.102 | 0.026 | 0.102 | Vanilloid 1 antagonist | | |
| 0.125 | 0.051 | 0.125 | MAP kinase 13 inhibitor | | |
| 0.139 | 0.066 | 0.139 | Aurora-C kinase inhibitor | | |
| 0.086 | 0.015 | 0.086 | mTOR inhibitor | | |
| 0.091 | 0.028 | 0.091 | Fibroblast growth factor 2 antagonist | | |
| 0.123 | 0.062 | 0.123 | Aurora-B kinase inhibitor | | |
| 0.081 | 0.023 | 0.081 | EphB4 antagonist | | |
| 0.105 | 0.047 | 0.105 | Hepatocyte growth factor antagonist | | |
| 0.082 | 0.025 | 0.082 | DNA gyrase inhibitor | | |
| 0.166 | 0.11 | 0.166 | Platelet aggregation inhibitor | | |
| 0.093 | 0.038 | 0.093 | Rho-associated kinase inhibitor | | |
| 0.11 | 0.055 | 0.11 | Protein kinase (CK2) inhibitor | | |
| 0.14 | 0.085 | 0.14 | MAP kinase kinase 4 inhibitor | | |
| 0.06 | 0.009 | 0.06 | DNA gyrase subunit B inhibitor | | |
| 0.085 | 0.035 | 0.085 | Check point kinase 1 inhibitor | | |
| 0.091 | 0.041 | 0.091 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | | |
| 0.11 | 0.061 | 0.11 | Granulocyte macrophage colony stimulating factor antagonist | | |
| 0.163 | 0.114 | 0.163 | Anticonvulsant | | |
| 0.096 | 0.048 | 0.096 | Stem cell growth factor agonist | | |
| 0.137 | 0.099 | 0.137 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | | |
| 0.063 | 0.024 | 0.063 | Proto-oncogene tyrosine-protein kinase Met inhibitor | | |
| 0.087 | 0.052 | 0.087 | AXL receptor tyrosine kinase inhibitor | | |
| 0.096 | 0.062 | 0.096 | MAP kinase kinase 1 inhibitor | | |
| 0.06 | 0.03 | 0.06 | Phosphatidylinositol 3-kinase alpha inhibitor | | |
| 0.065 | 0.035 | 0.065 | Cyclin D1 inhibitor | | |
| 0.063 | 0.034 | 0.063 | Fibroblast growth factor 4 antagonist | | |
| 0.077 | 0.05 | 0.077 | Protein kinase B gamma inhibitor | | |
| 0.094 | 0.067 | 0.094 | MAP kinase 9 inhibitor | | |
| 0.092 | 0.067 | 0.092 | Phosphodiesterase 7B inhibitor | | |
| 0.142 | 0.117 | 0.142 | Cyclin-dependent kinase 3 inhibitor | | |
| 0.075 | 0.05 | 0.075 | Rho-associated kinase II inhibitor | | |
| 0.105 | 0.085 | 0.105 | Cyclin-dependent kinase inhibitor | | |
| 0.04 | 0.026 | 0.04 | MAP3K5 inhibitor | | |
| 0.069 | 0.057 | 0.069 | Vanilloid antagonist | | |
| 0.053 | 0.041 | 0.053 | Phosphatidylinositol 3-kinase gamma inhibitor | | |
| 0.065 | 0.054 | 0.065 | HIV-1 reverse transcriptase inhibitor | | |
| 0.055 | 0.047 | 0.055 | Phosphatidylinositol kinase inhibitor | | |
| 0.044 | 0.038 | 0.044 | AMPA receptor antagonist | | |
| 0.097 | 0.093 | 0.097 | Activin receptor-like kinase 4 inhibitor | | |
| 0.05 | 0.046 | 0.05 | Tyrosine-protein kinase EMT inhibitor | | |
| 0.065 | 0.064 | 0.065 | MAP3K7 inhibitor | | |